These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28338430)

  • 1. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
    Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary breast and thyroid cancers (Israel).
    Sadetzki S; Calderon-Margalit R; Peretz C; Novikov I; Barchana M; Papa MZ
    Cancer Causes Control; 2003 May; 14(4):367-75. PubMed ID: 12846369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase.
    Lubina A; Cohen O; Barchana M; Liphshiz I; Vered I; Sadetzki S; Karasik A
    Thyroid; 2006 Oct; 16(10):1033-40. PubMed ID: 17042690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
    Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
    Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.
    Hung MH; Liu CJ; Teng CJ; Hu YW; Yeh CM; Chen SC; Chien SH; Hung YP; Shen CC; Chen TJ; Tzeng CH; Liu CY
    PLoS One; 2016; 11(2):e0148597. PubMed ID: 26894298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
    Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
    Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
    Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
    Lu CH; Lee KD; Chen PT; Chen CC; Kuan FC; Huang CE; Chen MF; Chen MC
    Eur J Endocrinol; 2013 Nov; 169(5):577-85. PubMed ID: 23939917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study of hairy cell leukemia in Israel.
    Paltiel O; Adler B; Barchana M; Dann EJ
    Eur J Haematol; 2006 Nov; 77(5):372-7. PubMed ID: 17044834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study.
    Ganti A; Plitt MA; Kuan EC; Kuhar HN; Batra PS; Tajudeen BA
    Int Forum Allergy Rhinol; 2018 Jun; 8(6):756-762. PubMed ID: 29381260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012.
    Crocetti E; Mattioli V; Buzzoni C; Franceschi S; Serraino D; Vaccarella S; Ferretti S; Busco S; Fedeli U; Varvarà M; Falcini F; Zorzi M; Carrozzi G; Mazzucco W; Gasparotti C; Iacovacci S; Toffolutti F; Cavallo R; Stracci F; Russo AG; Caldarella A; Rosso S; Musolino A; Mangone L; Casella C; Fusco M; Tagliabue G; Piras D; Tumino R; Guarda L; Dinaro YM; Piffer S; Pinna P; Mazzoleni G; Fanetti AC; Dal Maso L;
    Cancer Med; 2021 Oct; 10(19):6855-6867. PubMed ID: 34533289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
    Goldfarb M; Rosenberg AS; Li Q; Keegan THM
    Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
    Yang J; Wu F; An H; Gan H
    Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.